Medpace Holdings ROA 2014-2025 | MEDP
Current and historical return on assets (ROA) values for Medpace Holdings (MEDP) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Medpace Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.42B | $1.90B | 20.79% |
| 2024-12-31 | $0.40B | $2.10B | 20.45% |
| 2024-09-30 | $0.37B | $2.08B | 19.58% |
| 2024-06-30 | $0.34B | $1.92B | 19.83% |
| 2024-03-31 | $0.31B | $1.80B | 19.73% |
| 2023-12-31 | $0.28B | $1.66B | 19.03% |
| 2023-09-30 | $0.27B | $1.49B | 19.43% |
| 2023-06-30 | $0.27B | $1.41B | 19.62% |
| 2023-03-31 | $0.26B | $1.40B | 19.07% |
| 2022-12-31 | $0.25B | $1.35B | 18.36% |
| 2022-09-30 | $0.23B | $1.33B | 16.01% |
| 2022-06-30 | $0.21B | $1.32B | 14.18% |
| 2022-03-31 | $0.20B | $1.34B | 13.22% |
| 2021-12-31 | $0.18B | $1.66B | 11.82% |
| 2021-09-30 | $0.18B | $1.58B | 12.36% |
| 2021-06-30 | $0.17B | $1.47B | 12.41% |
| 2021-03-31 | $0.16B | $1.45B | 11.79% |
| 2020-12-31 | $0.14B | $1.39B | 11.41% |
| 2020-09-30 | $0.12B | $1.30B | 10.34% |
| 2020-06-30 | $0.11B | $1.22B | 9.36% |
| 2020-03-31 | $0.11B | $1.14B | 10.07% |
| 2019-12-31 | $0.10B | $1.14B | 9.44% |
| 2019-09-30 | $0.09B | $1.07B | 9.06% |
| 2019-06-30 | $0.09B | $1.02B | 8.83% |
| 2019-03-31 | $0.08B | $1.01B | 7.91% |
| 2018-12-31 | $0.07B | $0.97B | 7.57% |
| 2018-09-30 | $0.06B | $0.95B | 6.45% |
| 2018-06-30 | $0.05B | $0.97B | 5.52% |
| 2018-03-31 | $0.05B | $0.97B | 4.80% |
| 2017-12-31 | $0.04B | $0.95B | 4.07% |
| 2017-09-30 | $0.03B | $0.95B | 2.90% |
| 2017-06-30 | $0.02B | $0.96B | 2.37% |
| 2017-03-31 | $0.02B | $0.97B | 2.46% |
| 2016-12-31 | $0.01B | $0.98B | 2.66% |
| 2016-06-30 | $0.01B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.508B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| CVS Health (CVS) | United States | $84.718B | 10.53 |
| Cencora (COR) | United States | $54.879B | 19.08 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Revvity (RVTY) | United States | $10.756B | 18.51 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |